SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-11
👔
Latigo Biotherapeutics, Inc.
@LTGO_InsiderForm 4 Filing: Tananbaum James B. Buys $2.5M of $LTGO
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Latigo Biotherapeutics, Inc.
Ticker: $LTGO
Transaction Value
$2.5M
Price/Share: $0.27
transaction date
2026-08-10
Shares: 9,181,328
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Tananbaum James B., holds the title of Director at Latigo Biotherapeutics, Inc..
On 2026-08-10, the insider transacted 9,181,328 shares.The shares were transacted at a weighted average price of $0.27 per share, resulting in a total market-relevant value of $2.5M.
Executive Summary Summary
Tananbaum James B. (Director) bought $2.5M of $LTGO
Post-Transaction Position: 2,008,024 shares
SEC Accession No: 0001581754-26-000006 (CIK: 1581754)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.